Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni.

Di Bello E, Noce B, Fioravanti R, Zwergel C, Valente S, Rotili D, Fianco G, Trisciuoglio D, Mourão MM, Sales P Jr, Lamotte S, Prina E, Späth GF, Häberli C, Keiser J, Mai A

Open source

DOI: 10.1021/acsinfecdis.2c00232
Published: 2022 Jul 8
Container: ACS infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acsinfecdis.2c00232,
  title = {Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni.},
  author = {Di Bello E and Noce B and Fioravanti R and Zwergel C and Valente S and Rotili D and Fianco G and Trisciuoglio D and Mourão MM and Sales P Jr and Lamotte S and Prina E and Späth GF and Häberli C and Keiser J and Mai A},
  year = {2022},
  journal = {ACS infectious diseases},
  doi = {10.1021/acsinfecdis.2c00232},
  url = {https://doi.org/10.1021/acsinfecdis.2c00232}
}

RIS

TY  - JOUR
TI  - Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni.
AU  - Di Bello E
AU  - Noce B
AU  - Fioravanti R
AU  - Zwergel C
AU  - Valente S
AU  - Rotili D
AU  - Fianco G
AU  - Trisciuoglio D
AU  - Mourão MM
AU  - Sales P Jr
AU  - Lamotte S
AU  - Prina E
AU  - Späth GF
AU  - Häberli C
AU  - Keiser J
AU  - Mai A
PY  - 2022
JO  - ACS infectious diseases
DO  - 10.1021/acsinfecdis.2c00232
UR  - https://doi.org/10.1021/acsinfecdis.2c00232
ER  -

APA

E, D. B., B, N., R, F., C, Z., S, V., D, R., G, F., D, T., MM, M., Jr, S. P., S, L., E, P., GF, S., C, H., J, K., & A, M. (2022). Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni.. ACS infectious diseases. https://doi.org/10.1021/acsinfecdis.2c00232

Source records

pubmed · retrieved 2026-09-26T05:30:40.870Z